From August 15th to 16th, 2026, the First International Symposium on Advanced Drug Delivery Systems took place in Beijing, bringing together researchers, industry professionals, and academic experts from China and overseas.
The two-day event focused on some of the most important developments in modern drug delivery, including innovative drug carriers and formulations, targeted delivery, controlled release, responsive materials, nucleic acid delivery, vaccine delivery, and clinical translation. Participants shared recent research findings and discussed technical challenges as well as potential directions for future collaboration.
XGen Bio Engages in Advanced Drug Delivery Discussions
As an active participant in the event, XGen Bio took part in technical and academic discussions with professionals working across the drug delivery sector.
The rapid development of mRNA drugs and other nucleic acid-based therapies is creating new requirements for drug delivery technologies. A promising therapeutic molecule alone is not enough; an effective delivery system is often essential for protecting the payload, improving delivery efficiency, and achieving the desired biological effect.
Against this background, technologies such as lipid nanoparticles (LNPs), polymeric nanocarriers, microspheres, and responsive delivery materials continue to receive significant attention. Researchers and developers are increasingly focused on factors such as particle characteristics, delivery efficiency, safety, reproducibility, and the ability to move technologies from laboratory research toward practical applications.
Microfluidic Technology Is Becoming Increasingly Important
One of the areas closely connected with advanced nanomedicine preparation is microfluidic technology.
Compared with conventional preparation approaches, microfluidic systems can provide more controlled fluid mixing and process conditions. This makes the technology particularly relevant to the preparation and optimization of nanoscale drug delivery systems.
For research teams working with lipid nanoparticles and other nanomedicine formulations, process control can have a direct impact on the properties and consistency of the resulting formulation. As research progresses from early laboratory experiments toward larger-scale development, requirements for reproducibility, process stability, and operational efficiency become increasingly important.
For this reason, microfluidic devices and related equipment for LNP synthesis and nanomedicine preparation have become valuable tools in modern drug delivery research.
Connecting Academic Research With Practical Technology
For XGen Bio, participation in an international academic event is more than an opportunity to follow the latest scientific developments. It also provides a way to better understand the practical challenges faced by researchers and pharmaceutical development teams.
Through direct communication with researchers and industry professionals, equipment developers can gain a clearer understanding of emerging requirements in nanomedicine preparation and drug delivery.
XGen Bio continues to focus on nanomedicine preparation, microfluidic technology, and related equipment applications, while paying close attention to the changing needs of different research and development scenarios.
This connection between scientific research and practical equipment development can help transform new ideas into more useful and reliable laboratory technologies.
Looking Ahead to New Opportunities in Drug Delivery
Advanced drug delivery is developing rapidly, particularly with the growing interest in nucleic acid therapeutics, vaccines, and targeted medicines. As new delivery systems emerge, researchers will need technologies that provide greater control, reproducibility, flexibility, and efficiency during formulation development.
XGen Bio will continue strengthening its capabilities in technology research, product development, and application support for life science research and innovative drug development.
By maintaining communication with research institutions, pharmaceutical companies, and other industry partners, XGen Bio aims to respond to real-world research requirements and contribute to the continued development of nanomedicine preparation technology and advanced drug delivery systems.
The First International Symposium on Advanced Drug Delivery Systems provided an important opportunity for knowledge exchange and technical discussion. For companies such as XGen Bio, these interactions can also help identify new application needs and translate industry insights into future technology development.
www.xgenbiologics.com
XGen Biologics Technology Co., Ltd.
